mRNA vaccine

A melanoma vaccine built on mRNA technology is being highlighted in medical news. The approach, similar to the technology used in some Covid-19 vaccines, is being studied as a way to train the immune system to recognize and attack melanoma cancer cells. If proven effective in trials, it could add a new personalized immunotherapy option for patients with advanced skin cancer.